联合瘤内与瘤周多模态磁共振成像预测乳腺癌人表皮生长因子受体2表达水平
回顾性纳入82例术前行乳腺MRI并有术后HER-2病理结果的乳腺癌患者(阴性57例、阳性25例),采用3.0T MRI的IDEAL-IQ、MUSE-IVIM和MAGIC序列评估瘤内及瘤周参数。HER-2阳性与阴性组间FF-R1、R2∗-R1、MUSE-Dt-R1、MUSE-Dt-R2、MUSE-Dp-R2、MUSE-ADC-R2、T1-R2、T1+C-R1、T1+C-R2、T1+C-R3及sub-T1-R2存在显著差异;联合模型预测HER-2表达的AUC为0.822(P<0.001,95%CI 0.730–0.913),高于其他模型。作者认为基于术前乳腺MRI的瘤内与瘤周多模态参数有潜力无创评估乳腺癌HER-2状态。
要点
- 联合瘤内与瘤周多模态MRI参数的模型预测HER-2表达AUC=0.822(P<0.001,95%CI 0.730–0.913)。
- HER-2阳性与阴性组间FF-R1、R2∗-R1、MUSE-Dt-R1、MUSE-Dt-R2、MUSE-Dp-R2、MUSE-ADC-R2、T1-R2、T1+C-R1、T1+C-R2、T1+C-R3及sub-T1-R2存在显著差异。
- 联合模型对HER-2表达的诊断性能高于其他模型。
核心结论
- 基于术前乳腺MRI的瘤内与瘤周多模态MRI参数显示出无创评估乳腺癌HER-2状态的潜力。
研究设计与样本
- 回顾性研究纳入82例有术前MRI和术后HER-2病理评估的患者,分为HER-2阴性组(n=57)与阳性组(n=25),采用3.0T MRI的IDEAL-IQ、MUSE-IVIM和MAGIC序列,以术后病理HER-2表达为参考标准。
关键影像表现/征象
- 评估瘤内与瘤周参数包括脂肪分数(FF)、弛豫率(R2∗)、组织扩散系数(Dt)、伪扩散系数(Dp)、灌注分数(f)、表观扩散系数(ADC)、T1(-/+C)、T2(-/+C)及质子密度(PD,-/+C)。
- HER-2阳性与阴性组间FF-R1、R2∗-R1、MUSE-Dt-R1、MUSE-Dt-R2、MUSE-Dp-R2、MUSE-ADC-R2、T1-R2、T1+C-R1、T1+C-R2、T1+C-R3及sub-T1-R2存在显著差异。
诊断标准与关键数值
- 联合模型预测HER-2表达的AUC=0.822(P<0.001,95%CI=0.730,0.913)。
- 联合模型对HER-2表达的诊断性能高于其他模型。
临床应用与阅片要点
- 作者认为基于术前乳腺MRI的瘤内与瘤周多模态MRI参数有潜力用于无创评估乳腺癌HER-2状态。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: Human epidermal growth factor receptor-2 (HER-2), a proto-oncogene associated with breast cancer (BC) development and prognosis. This study investigated the predictive value of intratumoural and peritumoural multimodal magnetic resonance imaging (MRI) for HER-2 expression levels in BC.
MATERIALS AND METHODS: This retrospective study involved 82 patients with preoperative MRI and postoperative pathological evaluation for HER-2 expression, divided into negative (n = 57) and positive groups (n = 25). MRI was conducted using a 3.0T field strength and involved sequences including iterative decomposition of water and fat with echo asymmetry and least squares estimation quantification (IDEAL-IQ), multiplexed sensitivity encoding intravoxel incoherent motion (MUSE-IVIM), and magnetic resonance image complication (MAGIC). Assessment focused on intratumoural and peritumoural parameters such as fat fraction (FF), relaxation rate (R2∗), tissue diffusivity (Dt), pseudo-diffusivity (Dp), perfusion fraction (f), apparent diffusion coefficient (ADC), T1 (-/+C), T2 (-/+C), and proton density (PD, -/+C) to enhance differentiation between two groups. Statistical analyses included the Kolmogorov-Smirnov, Student's t-test, and Mann-Whitney U-test, along with logistic regression and receiver operating characteristic curves (AUC) for diagnostic performance evaluation.
RESULTS: There were significant differences in FF-R1, R2∗-R1, MUSE-Dt-R1, MUSE-Dt-R2, MUSE-Dp-R2, MUSE-ADC-R2, T1-R2, T1+C-R1, T1+C-R2, T1+C-R3, and sub-T1-R2 between the HER-2 positive and negative group. The ROC analysis showed that the combined model (AUC = 0.822, P < 0.001, 95% CI = 0.730, 0.913) had higher diagnostic performance for predicting HER-2 expression in BC than other models.
CONCLUSION: Intratumoural and peritumoural multimodal MRI parameters based on preoperative breast MRI showed potential for the noninvasive evaluation of HER-2 status in BC.
引用
- Feng W, Qu M, Xiong Y, et al. Combining intratumoral and peritumoral multimodality magnetic resonance imaging (MRI) to predict the expression level of human epidermal growth factor receptor-2 (HER-2) in breast cancer. Clin Radiol. 2025. PMID: 40939277. doi:10.1016/j.crad.2025.107019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。